跳至主要内容
临床试验/NCT05864183
NCT05864183招募中不适用

Screening for Risk Factors of Prediabetes Among Adults Patients at Sohag University Hospital

Sohag University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
comparison between the measurement of HbA1c in normal non prediabetics and prediabetics at Sohag university hospital .

研究概览

简要总结

  • Prediabetes is an intermediate state of hyperglycemia with glycemic parameters above normal but below the diabetes threshold..
  • during the average 3 years of follow-up Prediabetes is diagnosed based on laboratory tests: fasting plasma glucose level (100-125 mg/dl) ;HbA1c, (5.7-6.4%) or plasma glucose level after an oral glucose tolerance test ( 140-199 mg/dl).
  • Reports estimate that more than 470 million people will have prediabetes by 2030.
  • According to an expert panel of the American Diabetes Association, up to 70% of individuals with prediabetes will eventually develop diabetes.
  • Observational evidence suggests as association between prediabetes and complications of diabetes such early nephropathy(10%) , small fiber neuropathy(18-25 %), early retinopathy (8-12%) and risk of macrovascular disease (52%) .
  • Screening for prediabetes is designed to save lives or enhance an individual's quality of life by early detection so that screening will minimize the risk of developing diabetes or its complications .

详细描述

  • In this case control study we aim to screen for risk factors of prediabetes among adult patients to minimize the risk of developing diabetes or its complications .
  • Prediabetes screening is also required to minimize medical costs such as hospitalization, outpatient care, surgery, medications, and laboratory test costs .
  • Several studies had shown efficacy of lifestyle interventions in diabetes prevention by targeting obesity with increase in physical activity and dietary changes with a relative risk reduction of 40%-70% in adults with prediabetes ,also there is increasing evidence to prove the efficacy of pharmacotherapy in prevention of diabetes in adults with prediabetes

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient above 18 years old .

排除标准

  • all patients known to be diabetics .
  • pregnancy .
  • chronic depleting diseases,
  • Those who were taking drugs known to influence blood glucose levels e.g. metformin, thiazolidinedione and steroids.

结局指标

主要结局

comparison between the measurement of HbA1c in normal non prediabetics and prediabetics at Sohag university hospital .

时间窗: 6 months

analysis of HbA1c measurements and compare the results in both groups

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nermin Fathy Ezzat

internal medicine resident at faculty of medicine Sohag university

Sohag University

研究点 (1)

Loading locations...

相似试验